Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BLACK DIAMOND THERAPEUTICS, INC.

(BDTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
9.7(c) 9.34(c) 9.64(c) 9.9(c) 9.5(c) Last
125 070 231 312 260 417 253 881 660 803 Volume
-1.62% -3.71% +3.21% +2.70% -4.04% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -136 M - -
Net cash position 2021 208 M - -
P/E ratio 2021 -2,52x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -157 M - -
Net cash position 2022 33,0 M - -
P/E ratio 2022 -2,37x
Yield 2022 -
Capitalization 344 M 344 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 69
Free-Float 96,6%
More Financials
Company
Black Diamond Therapeutics, Inc. is a precision oncology medicine company. The Company’s technology platform, Mutation-Allostery-Pharmacology (MAP) platform is designed to allow it to analyze population-level genetic sequencing data to identify oncogenic mutations that promote cancer across tumor types, group these mutations into families and develop a single small molecule therapy in a tumor-agnostic manner that... 
More about the company
Ratings of Black Diamond Therapeutics, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
C-
More Ratings
All news about BLACK DIAMOND THERAPEUTICS, INC.
09/03VC DAILY : Question: What Is Driving Startup Mergers and Acquisitions?
DJ
08/17BLACK DIAMOND THERAPEUTICS : Wedbush Lowers PT for Black Diamond Therapeutics to..
MT
08/17BLACK DIAMOND THERAPEUTICS : Berenberg Bank Adjusts Black Diamond Therapeutics P..
MT
08/12BLACK DIAMOND : Q2 Earnings Snapshot
AQ
08/12Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and ..
GL
08/12BLACK DIAMOND THERAPEUTICS : Earnings Flash (BDTX) BLACK DIAMOND THERAPEUTICS Po..
MT
08/12BLACK DIAMOND THERAPEUTICS : Reports Second Quarter 2021 Financial Results and P..
PU
08/12Black Diamond Therapeutics, Inc. Reports Unaudited Consolidated Earnings Resu..
CI
08/12BLACK DIAMOND THERAPEUTICS : Management's Discussion and Analysis of Financial C..
AQ
08/12BLACK DIAMOND THERAPEUTICS, INC. : Results of Operations and Financial Condition..
AQ
08/10BLACK DIAMOND THERAPEUTICS : Announces Appointment of Mark Velleca, M.D., Ph.D. ..
PU
08/10BLACK DIAMOND THERAPEUTICS, INC. : Change in Directors or Principal Officers (fo..
AQ
08/10BLACK DIAMOND THERAPEUTICS : Announces Appointment of Mark Velleca, M.D., Ph.D. ..
AQ
08/10Black Diamond Therapeutics, Inc. Announces Mark Velleca to Board of Directors
CI
08/05BLACK DIAMOND THERAPEUTICS, INC. : Change in Directors or Principal Officers (fo..
AQ
More news
News in other languages on BLACK DIAMOND THERAPEUTICS, INC.
07/23DGAP-NEWS : Biotechbranche mit solidem 2. Quartal -2-
04/23DGAP-NEWS : BB BIOTECH AG: Erfolgreiche -2-
More news
Analyst Recommendations on BLACK DIAMOND THERAPEUTICS, INC.
More recommendations
Chart BLACK DIAMOND THERAPEUTICS, INC.
Duration : Period :
Black Diamond Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BLACK DIAMOND THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 9,50 $
Average target price 34,50 $
Spread / Average Target 263%
EPS Revisions
Managers and Directors
David M. Epstein President, Chief Executive Officer & Director
Thomas Leggett Chief Financial Officer
Robert Alexander Ingram Chairman
Elizabeth Buck CSO, EVP-Discovery & Translational Sciences
Karsten Witt Chief Medical Officer & VP-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
BLACK DIAMOND THERAPEUTICS, INC.-70.36%344
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
WUXI APPTEC CO., LTD.35.75%69 350
REGENERON PHARMACEUTICALS34.93%67 775
VERTEX PHARMACEUTICALS-20.33%48 850